This series takes a fresh, sometimes challenging, look at some of the issues facing the actuarial profession and society
The ‘think’ series aims to promote debate on topics across the spectrum of actuarial work and beyond. It looks to provide a platform for members and stakeholders to share views that may differ from the IFoA’s ‘house’ view.
Through this, we hope to challenge the status quo within the profession, question orthodoxy, and shine a light on complex or under-examined issues. At its heart, the series is about stimulating discussion and dialogue to help tackle issues from a different perspective.
The fourteenth edition in our ‘think’ series has been authored by Mei Sum Chan, Sreenidhi Venkatesh and Stuart McDonald from Lane Clark and Peacock’s Health Analytics Team. Mei also serves as a member of the IFoA Health and Care Board and Stuart is Deputy Chair of the Continuous Mortality Investigation and founded the influential Covid-19 Actuaries Response Group.
In this piece, the authors consider the economic and societal impacts that the development of antiobesity medications (AOMs) will have on insurance, pension schemes, public policy and the future economic and healthcare landscape.
Read the full piece to find out how the evolving burden of obesity and increasing use of weight management strategies will impact population demographics and the economy.
Don’t miss the chance to join Stuart McDonald on 12 November, 12:00 to 12:30 PM for an engaging Q&A session on IFoA Communities. He will take a deeper look into the think piece and answer your questions live.
If you have any questions or would like to contribute to a future ‘think’ piece, please contact the IFoA Policy Team.
